Received Mar 18, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TYP | TYPHOID LIVE ORAL TY21A (VIVOTIF) | BERNA BIOTECH, LTD. | UNK | Unknown | — |
The patient took Vivotif with coffee; Case reference number US-BN-2025-000903 is a spontaneous case initially received from a consumer via agency (reference number: USBAV25-1014) on 02-May-2025 and concerns a patient of unspecified age and gender. The patient's medical history and concomitant medication details were not provided. On unspecified date, the patient with food took a dose of Vivotif vaccine (batch number: unknown) at unknown dose, route or site of administration, for unknown indication (explicitly coded as 'product administration error ') At the time of initial report, it was unknown if the patient experienced any of adverse events due to Vivotif. No further information was provided.; Reporter's Comments: A patient of unspecified age and gender took a dose of Vivotif vaccine with food for unknown indication, which is considered as product administration error. It was unknown if the patient experienced any of adverse events due to Vivotif. Product administration error is considered as listed per company convention. The patient's medical history and concomitant medication details were not provided. Product administration error is not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.; Sender's Comments: A patient of unspecified age and gender took a dose of Vivotif vaccine with food for unknown indication, which is considered as product administration error. It was unknown if the patient experienced any of adverse events due to Vivotif. Product administration error is considered as listed per company convention. The patient's medical history and concomitant medication details were not provided. Product administration error is not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.
Comments: NONE